Search

You searched for "safety"

599 results found

Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema

1 April 2015 | | EYE - Vitreo-Retinal
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
Ocular immunology and inflammation journal cover image.

The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease

2 August 2024 | | EYE - Vitreo-Retinal
In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...

Glaukos at ESCRS 2025

11 December 2025 | Company Profiles, Awards, Conferences & Anniversaries
The 2026 ESCRS meeting in Copenhagen was a highly successful and busy event for Glaukos, highlighted by the launch of iStent infinite®. The new device was prominently featured across podium presentations, booth speaker sessions, and hands-on dry labs, following its...

Burning vision: vision loss from misuse of ‘toy’ laser pens in children

1 April 2014 | | EYE - Cornea
A case series of five children with macular burns due to the misuse of novelty laser products, purchased online or abroad, was undertaken at the Royal Hallamshire Hospital and The Children’s Hospital, Sheffield [1]. All patients were from the Sheffield...

Research into headlight glare commissioned by government

6 November 2024 | research, government, optometry, optometrist
The government has commissioned much needed research into the causes of night-time headlight glare, after campaigning involving the College of Optometrists among others. The College spearheaded the lobbying on behalf of the optical sector, in collaboration with colleagues from the...

A unique case of macular burn from ‘toy’ laser

2 February 2024 | | EYE - General
The first laser was created in 1960 and its name is an acronym for ‘light amplification by stimulated emission of radiation’. Laser technology has been used for medical, industrial, research and entertainment purposes in a variety of fields following extensive...

Development of a modern surgical simulation suite to promote safer ophthalmic surgical training

5 August 2020 | | EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - Orbit, EYE - General
For trainees, having access to surgical simulation equipment is more important than ever. The authors describe the creation of a bespoke teaching and training suite in Glasgow to help trainees develop their skills and promote surgical excellence. Simulation has become...

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

18 September 2023 | Glaucoma, CID, Ciliatech, Research
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.

Setting up successful safe & efficient nurse-led intravitreal injection service

28 January 2020 | | EYE - Vitreo-Retinal, EYE - General
In September 2019, we organised a training course at Great Western NHS Hospital (GWH), Swindon, which provided presentations, discussions and hands-on wet lab experience on how to perform intravitreal injection using intravitreal assisted device (INVITRIA) for nurses and doctors from...

Addressing medical risk factors for diabetes and understanding the new systemic treatments

1 February 2014 |
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...

Oertli Instrumente AG wins the Swiss Medtech Award

12 June 2024 | Awards, Conferences & Anniversaries, Company Profiles
Oertli Instrumente AG has been honored with the prestigious Swiss Medtech Award, worth CHF 75,000 at the Swiss Medtech Day.

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...